The Indian pharmaceutical market continued rising in April 2025, achieving a strong annual growth of 7.8%, with total sales reaching a remarkable Rs 19,711 crore.
According to a report by Pharmatrack, the sector recorded an impressive Rs 1,424 crore in additional sales this month, highlighting its continued resilience and strong demand.
The report attributed the growth primarily to price-led expansion, as well as the impact of new product introductions (NIS). On a moving annual total (MAT) basis, the industry surged to Rs 2,27,361 crore, reflecting an 8.3 per cent increase year-on-year and a healthy 10.3 per cent Compound annual growth rate (CAGR). These figures highlight the sector’s long-term growth potential and strong position in the market.
